A1IKL3 AF NFT

Chymotrypsin inhibitor Ani s 6

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeical27mjmnwoov3bre2vliv3p7wznkhwhxslaydl7akyiyx4hgbve/metadata.json
IPFS of structure file: 
bafybeie62ld4mjkaxczgn63kyxplpq6kiplmyu6vmp7jgwe6vgdq22xlfa/AF-A1IKL3-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x362a6d063b1B7E1B6EfD3A9A7CA3612e3FE037AA
First NFT owner address (bech32): 
genesis1xc4x6p3mrdlpkmha82d8egmp9cl7qda2uxz2xy
Current NFT ID #16316 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
16316
Accession (UniProt):
A1IKL3
Name::
Chymotrypsin inhibitor Ani s 6
Experimental Method:
Predicted structure
Sequence source:
ANISAKIS SIMPLEX

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A1IKL3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A1IKL3|ANIS6_ANISI Chymotrypsin inhibitor Ani s 6 OS=Anisakis simplex OX=6269 PE=1 SV=1 MFQSTFFLVLMVCVATARFANKDHCPPNEEYNECGNPCQEKCDNGEPVICTYQCEHRCFCKQGYVRLTEDGECVPEEFCKPIHY